AngioDynamics (ANGO) vs Avita Medical (RCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Avita Medical (RCEL) has outperformed AngioDynamics (ANGO) over the past year, gaining 312.1% versus a loss of 9.5%. Over five years, RCEL leads with a +10.8% price change compared with -60.3% for ANGO. Avita Medical is the larger company by market cap ($495.0 million vs $454.6 million), about 1.1 times the size.
AngioDynamics converts more of its revenue into profit, with a net margin of -11.5% versus -67.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | RCEL |
|---|---|---|
| Share price | $10.81 | $15.62 |
| Market cap | $454.61M | $494.96M |
| 1-day change | +0.46% | -2.31% |
| YTD return | -15.81% | +352.75% |
| 1-year return | -9.54% | +312.14% |
| 5-year return | -60.29% | +10.78% |
| EPS (TTM) | $-0.78 | $-1.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $320.17M | $71.61M |
| Revenue growth (YoY) | +9.46% | +11.45% |
| Net income (latest FY) | $-36.74M | $-48.59M |
| Gross margin | 54.62% | 82.13% |
| Operating margin | -12.47% | -59.40% |
| Net margin | -11.48% | -67.85% |
| 52-week high | $16.29 | $18.43 |
| 52-week low | $9.39 | $3.22 |
| Distance from 52-week high | -33.64% | -15.25% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +82.70% | +32.46% |
| Average volume | 651.16K | 417.02K |
| Shares outstanding | 42.05M | 31.69M |
| Employees | 632 | 226 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCEL has outperformed ANGO by 321.7 percentage points over the past year.
- AngioDynamics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -67.8 cents for Avita Medical.
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Health Care · Medical/Dental Instruments · 632 employees
About Avita Medical
RCEL stock →AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Health Care · Medical/Dental Instruments · 226 employees
ANGO vs RCEL FAQ
Which is bigger, AngioDynamics or Avita Medical?
Avita Medical (RCEL) is larger, with a market capitalization of $494.96M compared with $454.61M for AngioDynamics (ANGO).
Which stock has performed better over the past year, ANGO or RCEL?
RCEL returned +312.14% over the past 12 months, compared with -9.54% for ANGO (price return, excluding dividends). Past performance does not predict future results.
Are AngioDynamics and Avita Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.